Scottish companies win £1.7m UK Government funding for healthcare innovation
Three Scottish companies are to receive funding for health tech research as part of the UK Government investment in developing technology to transform health and social care. The projects are being supported as part of its Industrial Strategy Challenge Fund, managed by UK Research and Innovation.
“Scottish companies are at the forefront of life science developments, and this UK Government funding will help them develop their expertise even further,” said Lord Iain Duncan, UK Government minister for Scotland.
The funded companies are:
- RoslinCT, Edinburgh – £887,000 to develop stem cell therapies for clinical use, working with ReproCELL.
- Stormid, Edinburgh/Glasgow – £586,000 to develop digital services for patients with lung conditions.
- Daysix, Edinburgh – £290,000 to develop a clinical decision support app with the potential to transform the delivery of trauma care globally.
Ian Campbell, executive chair of Innovate UK, said: “The projects we have funded today aim to make a real difference for patients and clinicians. They represent the very best of British innovation, focusing on improved patient outcomes and driving efficiency.
“The UK health sector is thriving, with SMEs playing a crucial role. By supporting this sector, as part of the government’s modern industrial strategy, we can ensure we remain global leaders in health innovation and create the jobs of tomorrow.”
Greg Clark, the UK Business Secretary, added: “Technology is revolutionising industries across our economy, and new innovations play a key role in advancing our healthcare sector to make sure people are living longer, healthier and happier lives.
“By pooling the expertise of the public and private sectors, as highlighted through the Life Sciences Sector Deal and the modern Industrial Strategy, we are making every opportunity to reach our full potential in finding new discoveries and technologies to diagnose illnesses earlier that could lead to more lives being saved.”